Post by Cork Chamber

In the latest edition of Chamberlink, our Innovation Series explores how global supply chains are evolving to become more intelligent, adaptive and even self-healing. Sylvia Kiely MBA, Vice President, Global Supply Chain and Product Strategy at Alexion AstraZeneca Rare Disease, shares how systems can sense disruption early, resolve routine issues automatically, and empower expert teams to focus on the decisions that matter most. A compelling perspective on innovation, resilience and patient impact from one of Cork’s leading voices in life sciences. Read the full article: https://lnkd.in/d_y4RZAA Alexion Pharmaceuticals, Inc. AstraZeneca